Food

ANNUAL REPORT OF RANBAXY 2010-11 PDF

Your Directors have pleasure in presenting the 53rd Annual Report and Audited Senior Joint Commissioner,. Kolkata. Delhi Value Added Tax. Ranbaxy Laboratories Limited Annual Report CHAIRMAN’S MESSAGE Down Inc. Germany (upto 16 December ) 11 Ranbaxy Unichem Co. Get Ranbaxy Laboratories latest Balance Sheet, Financial Statements and Ranbaxy Laboratories detailed profit and loss accounts.

Author: Kaziktilar Voodoozahn
Country: Malta
Language: English (Spanish)
Genre: Travel
Published (Last): 6 December 2010
Pages: 290
PDF File Size: 14.3 Mb
ePub File Size: 1.24 Mb
ISBN: 977-2-92269-875-3
Downloads: 95490
Price: Free* [*Free Regsitration Required]
Uploader: Malashura

The ineffectiveness arising from cash fow hedges which was recognised in Statement of Proft and Loss was not material. Description cannot exceed characters.

Ranbaxy Laboratories Limited (BSE Code: ) annual reports starting from year

Nifty pares losses; Ranbaxy,Cipla lead 25 Sep 09 We are attempting to resolve this funny technical issue! The Company expects to resume API bulk shipments to EU countries from Toansa manufacturing facility upon receipt of clearances from relevant regulatory authorities. Further, the Company has deposited Rs.

Your Account is not yet activated Click ranhaxy to receive activation mail once again. RANBAXY Business Profile Ranbaxy Laboratories manufactures and markets pharmaceutical dosage forms for human health careanimal health care products, bulk drugs and intermediates, diagnostics, laboratory chemicals and reagents.

The Company has not accepted the same and has fled its objections before the DRP.

Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol. Please do try to use an alternate pdf reader in case the file is unopenable with adobe.

It is the largest exporter of bulk drugs and pharmaceutical dosag. Segment information In accordance with AS 17, Segment Reporting, segment information has been given in the consolidated fnancial statements of the Company, and therefore, no separate disclosure on oc information is given in these fnancial statements. The Company will issue shares to the Trust which will allocate the shares to the respective employees upon exercise of stock options from time to time under ESOP – Consequently, stock write off and other costs of Rs.

  CAN BOGAZDAN CIKAR PDF

You will be able to download it at any time during the subscription period.

Please do reach out to us at contactus reportjunction. Key markets of US, Europe not so promising 27 Oct 09 However, considering the above matters relating to the Toansa anual facility, provisions primarily relating to inventories, trade commitments, sales return etc.

Hence, the Company has become a potentially sick company in terms of the provisions of Sick Industrial Companies Special Provisions Act, and requisite compliances under this Act would be made by the Company. Dion Global Solutions Limited. Click here to change registered Email ID. Contingent liabilities and commitments to the extent not provided for As at As at 31 March 31 December Contingent liabilities i Guarantees a Letter of comfort on behalf of subsidiaries, to the extent of limits 6, The effective portion of such cash fow hedges was recorded as part of reserves and surplus within hedging reserve and re-classifed in the Statement of Proft and Loss in the period corresponding to the occurrence of the highly probable forecasted transactions.

Since the matter involves signifcant judgement and in view of the inherent uncertainty of the present situation, the actual amounts may differ eventually. Pending disposal of the matter, the management considers the impact as unascertainable.

Ranbaxy Laboratories Balance Sheet, Ranbaxy Laboratories Financial Statement & Accounts

Options lapse, if they are not exercised prior to the expiry date, which is ten years from the date of grant. ESOS provides that the grant price of options will be the latest available closing price on the stock exchange on which the shares of the Company 2001-11 listed, prior to the date of the meeting of the Committee in which the options are granted.

  GRUNDIG MEGATRON BEDIENUNGSANLEITUNG PDF

The Off has also issued redeemable non-convertible debentures which are listed for trading on the NSE in India.

Ranbaxy UK Limited, U. The Company has challenged the order before the Hon”ble Income Tax Appellate Tribunal ITAT and pending disposal of the matter, the management considers the amount of tax liability as unascertainable.

Annual Reports & Presentations

Ranbaxy gets approval from Japan for Dewas unit; stk up 24 Jul 09 The Company received the fnal assessment order from the AO in November whereby demand of Rs Pursuant to the transaction, the Company anmual recorded a gain of Rs. ESOP – provides that the grant price will be the face value of the equity share.

The sales consideration of Rs. As per the Scheme, the share exchange ratio has been proposed as 0.

The Company is fully cooperating with this information request and is in dialogue with the US DOJ for submission of the requisite information. The Company expects to resume the operations shortly. The amount is excluding interest and penalty, if any.

The amount recognised in the Statement of Proft and Loss represents consequential cost sales return, inventory write off and customer claim recognised by the Company. Options lapse, if they are not exercised prior to the expiry date, which is three months from rabnaxy date of the vesting. The following are the outstanding derivative contracts entered into by the Company: These derivatives are not used for trading or speculation purposes.